BiotechTV – News
BiotechTV - News
Podcast Description
This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Podcast Insights
Content Themes
Covers a range of critical topics in the biotech sector, including partnerships, gene therapies, and investment strategies, with episodes featuring discussions about Stoke Therapeutics' partnership with Biogen for Dravet syndrome treatment and Solid Biosciences' data release on its microdystrophin gene therapy candidate for Duchenne muscular dystrophy.
This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
He discusses regulatory feedback the company has received that might allow it to earn an accelerated approval in antitrypsin deficiency. Plus, filing for sickle cell later this year, and how he thinks about new targets.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.